日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ubiquitination of Rhomboid 5 Homolog 2 by Constitutive Photomorphogenic 1 Alleviates Hepatic Ischemia-reperfusion Injury by Regulating the Transforming Growth Factor-β Activating Kinase 1-C-Jun N-terminal Kinase/p38 Signaling Pathway.

组成型光形态发生蛋白 1 对 Rhomboid 5 同源物 2 的泛素化通过调节转化生长因子-β激活激酶 1-C-Jun N 端激酶/p38 信号通路减轻肝脏缺血再灌注损伤。

Li Wendong, Wu Tongtong, Li Hao, Guan Zhenyu, Ding Mingjie, Guo Wenzhi

TM9SF1 Aggravates Liver Ischemia-Reperfusion Injury by Promoting Autophagy

TM9SF1通过促进自噬加重肝脏缺血再灌注损伤

Wu, Tongtong; Li, Wendong; Zhu, Ying; Liu, Xudong; Yu, Haocheng; Li, Hao; Zhang, Jiakai; Tang, Hongwei; Ding, Mingjie; Guo, Wenzhi

Six-Transmembrane Epithelial Antigen of the Prostate 1 Promotes HCC Proliferation and Metastasis in vitro and in vivo via the Wnt/β-Catenin Signaling Pathway

前列腺六跨膜上皮抗原1通过Wnt/β-catenin信号通路在体外和体内促进肝细胞癌的增殖和转移

Liu, Haichao; Gao, Jie; Liu, Xudong; Guo, Wenzhi; Zhang, Shuijun

Erratum: [Corrigendum] FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo

勘误:[更正] FXR1 在体外和体内均能促进肝细胞癌的增殖、侵袭和迁移

Zhao, Kun; Gao, Jie; Shi, Jihua; Shi, Chengcheng; Pang, Chun; Li, Jie; Guo, Wenzhi; Zhang, Shuijun

Nanotuner targeting mitochondrial redox and iron homeostasis imbalance for the treatment of acute liver injury.

纳米调节剂靶向线粒体氧化还原和铁稳态失衡,用于治疗急性肝损伤。

Li Minghao, Yang Qiwei, Gao Jie, Liu Xudong, Shi Jihua, Guo Wenzhi, Zhang Yi, Yu Qiwen, Sun Xinzhi, Zhang Shuijun

SIRT4-Mediated Deacetylation of PRDX3 Attenuates Liver Ischemia Reperfusion Injury by Suppressing Ferroptosis

SIRT4介导的PRDX3去乙酰化通过抑制铁死亡减轻肝脏缺血再灌注损伤。

Yu, Qiwen; Yang, Dongjing; Ran, Binli; Pan, Jie; Song, Yaodong; Cui, Mengwei; He, Qianqian; Mei, Chaopeng; Wang, Haifeng; Li, Huihui; Li, Guanghui; Meng, Yinuo; Wang, Fazhan; Guo, Wenzhi; Zhu, Changju; Chen, Sanyang

RNA m5C methylation in cancer: mechanisms and biological impact

癌症中的RNA m5C甲基化:机制和生物学影响

Guan, Zhenyu; Li, Wendong; He, Yuting; Guo, Wenzhi

m(6)A methylation-mediated lncRNA RNF144A-AS1 promotes hepatocellular carcinoma progression through the miR-1301-3p/RNF38 pathway

m(6)A甲基化介导的lncRNA RNF144A-AS1通过miR-1301-3p/RNF38通路促进肝细胞癌进展。

Kong, Minyu; Li, Wendong; Li, Hao; Jing, Yifan; Xu, Min; He, Yuting; Guo, Wenzhi

Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia.

药理学抑制 ENaC 或 NCX 可减轻高钠血症加剧的肝脏缺血再灌注损伤

Chen Yabin, Li Hao, Wen Peihao, Zhang Jiakai, Wang Zhihui, Cao Shengli, Guo Wenzhi

CCNE1 Promotes the Progression of Hepatic Precancerous Lesion and the Malignant Phenotype of Hepatocellular Carcinoma.

CCNE1促进肝脏癌前病变的进展和肝细胞癌的恶性表型

Zhang Kai, Hu Xue, Yao Lichao, Guo Wenzhi